Toxicological  	Toxicological  	 JJ	B-NP
assessment  	assessment  	 NN	I-NP
of  	of  	 IN	I-NP
nanostructured  	nanostructured  	 JJ	I-NP
silica 	silica 	 NN	I-NP
.  	.  	 .	O
II 	II 	 NNP	O
.  	.  	 .	O
Enzymatic 	Enzymatic 	 NNP	B-NP
,  	,  	 ,	O
biochemical  	biochemical  	 JJ	B-NP
indices 	indices 	 NNS	I-NP
,  	,  	 ,	O
state  	state  	 NN	O
of  	of  	 IN	O
antioxidative  	antioxidative  	 FW	B-NP
defence  	defence  	 FW	I-NP
Nanostructured  	Nanostructured  	 FW	O
silica  	silica  	 FW	B-NP
( 	( 	 -LRB-	O
SiO2 	SiO2 	 NNP	B-NP
)  	)  	 -RRB-	O
Aerosil  	Aerosil  	 NNP	B-NP
with  	with  	 IN	O
the  	the  	 DT	O
size  	size  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
primary  	primary  	 JJ	B-NP
nanoparticles  	nanoparticles  	 NNS	I-NP
( 	( 	 -LRB-	O
NPs 	NPs 	 NNP	B-NP
)  	)  	 -RRB-	O
of  	of  	 IN	O
5-30  	5-30  	 CD	O
nm 	nm 	 NN	B-NP
,  	,  	 ,	O
in  	in  	 IN	O
the  	the  	 DT	O
form  	form  	 NN	O
of  	of  	 IN	O
ultrasound  	ultrasound  	 NN	O
treated  	treated  	 VBN	B-NP
water  	water  	 NN	I-NP
suspension  	suspension  	 NN	I-NP
was  	was  	 VBD	O
administered  	administered  	 VBN	O
to  	to  	 TO	O
rats  	rats  	 VB	O
of  	of  	 IN	O
80  	80  	 CD	O
±  	±  	 CD	O
4  	4  	 CD	O
g  	g  	 CD	O
initial  	initial  	 JJ	O
body  	body  	 NN	O
weight  	weight  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
30  	30  	 CD	O
days  	days  	 NNS	O
by  	by  	 IN	O
intragastric  	intragastric  	 JJ	B-NP
gavage  	gavage  	 NN	I-NP
and  	and  	 CC	O
then  	then  	 RB	O
for  	for  	 IN	O
62  	62  	 CD	O
days  	days  	 NNS	O
with  	with  	 IN	O
diets  	diets  	 VBG	O
consumed  	consumed  	 VBN	O
in  	in  	 IN	O
doses  	doses  	 NNS	O
of  	of  	 IN	O
0.1 	0.1 	 CD	O
;  	;  	 :	O
1.0 	1.0 	 CD	O
;  	;  	 :	O
10  	10  	 CD	O
and  	and  	 CC	O
100  	100  	 CD	O
mg 	mg 	 CD	B-NP
/ 	/ 	 CD	I-NP
kg  	kg  	 JJ	I-NP
body  	body  	 NN	I-NP
weight  	weight  	 NN	I-NP
per  	per  	 IN	O
day 	day 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
control  	control  	 NN	B-NP
group  	group  	 NN	I-NP
received  	received  	 VBD	I-NP
vehicle  	vehicle  	 NN	I-NP
of  	of  	 IN	O
nanomaterial  	nanomaterial  	 NNS	B-NP
( 	( 	 -LRB-	O
NM 	NM 	 NNP	B-NP
) 	) 	 -RRB-	O
--deionized  	--deionized  	 JJ	O
water 	water 	 NN	O
.  	.  	 .	O
There  	There  	 EX	O
were  	were  	 VBD	O
measured  	measured  	 VBN	O
in  	in  	 IN	O
liver  	liver  	 NN	O
of  	of  	 IN	O
ani-  	ani-  	 JJ	B-NP
mals  	mals  	 NNS	I-NP
the  	the  	 DT	O
content  	content  	 NN	O
of  	of  	 IN	O
total  	total  	 JJ	B-NP
cytochromes  	cytochromes  	 JJ	I-NP
P450  	P450  	 NN	I-NP
and  	and  	 CC	O
b5  	b5  	 CD	O
in  	in  	 IN	O
the  	the  	 DT	O
microsomal  	microsomal  	 JJ	B-NP
fraction  	fraction  	 NN	I-NP
of  	of  	 IN	O
liver 	liver 	 NN	O
,  	,  	 ,	O
activity  	activity  	 NN	O
( 	( 	 -LRB-	O
Vmax 	Vmax 	 NNP	B-NP
)  	)  	 -RRB-	O
of  	of  	 IN	O
microsomal  	microsomal  	 JJ	B-NP
monooxygenases  	monooxygenases  	 NN	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
mixed  	mixed  	 JJ	O
func-  	func-  	 JJ	B-NP
tion  	tion  	 NN	I-NP
of  	of  	 IN	I-NP
isoforms  	isoforms  	 CD	I-NP
CYP1A1 	CYP1A1 	 CD	O
,  	,  	 ,	O
1A2  	1A2  	 NNP	B-NP
and  	and  	 CC	O
2B1  	2B1  	 CD	B-NP
on  	on  	 IN	O
their  	their  	 PRP$	O
specific  	specific  	 JJ	O
substrates 	substrates 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
activity  	activity  	 NN	O
of  	of  	 IN	O
conjugating  	conjugating  	 FW	B-NP
liver  	liver  	 FW	I-NP
enzymes  	enzymes  	 FW	I-NP
glutathione-S-transferase  	glutathione-S-transferase  	 FW	I-NP
and  	and  	 CC	O
UDP-glucuronosyl-transferase  	UDP-glucuronosyl-transferase  	 JJ	B-NP
in  	in  	 IN	O
microsomal  	microsomal  	 JJ	B-NP
fraction  	fraction  	 NN	I-NP
and  	and  	 CC	O
cytosol 	cytosol 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
total  	total  	 NN	O
and  	and  	 CC	O
non  	non  	 JJ	B-NP
sedimentable  	sedimentable  	 JJ	I-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
lysosomal  	lysosomal  	 JJ	I-NP
hydrolases  	hydrolases  	 NNS	I-NP
( 	( 	 -LRB-	O
β-glucuronidase 	β-glucuronidase 	 NNP	B-NP
,  	,  	 ,	O
β-galactozydase 	β-galactozydase 	 NNP	B-NP
,  	,  	 ,	O
arylsulphatase  	arylsulphatase  	 VBG	O
A 	A 	 DT	O
,  	,  	 ,	O
B 	B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
content  	content  	 NN	O
of  	of  	 IN	O
PUFA 	PUFA 	 NNP	O
's  	's  	 POS	O
diene  	diene  	 JJ	O
conjugates  	conjugates  	 NN	O
and  	and  	 CC	O
TBA-reactive  	TBA-reactive  	 JJ	B-NP
substances  	substances  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
blood  	blood  	 NN	B-NP
plasma  	plasma  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
activity  	activity  	 NN	O
of  	of  	 IN	O
antioxidative  	antioxidative  	 JJ	B-NP
enzymes  	enzymes  	 NNS	I-NP
( 	( 	 -LRB-	O
glutathionperoxidase 	glutathionperoxidase 	 UH	B-NP
,  	,  	 ,	O
superoxidedismutase 	superoxidedismutase 	 NN	B-NP
,  	,  	 ,	O
glutathionreductase 	glutathionreductase 	 NN	B-NP
,  	,  	 ,	O
katalase 	katalase 	 CD	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
erytrocytes  	erytrocytes  	 NN	B-NP
were  	were  	 VBD	O
estimated 	estimated 	 VBN	O
.  	.  	 .	O
A  	A  	 DT	O
set  	set  	 NN	O
of  	of  	 IN	O
standard  	standard  	 JJ	O
biochemical  	biochemical  	 JJ	B-NP
parameters  	parameters  	 NNS	I-NP
of  	of  	 IN	I-NP
blood  	blood  	 NN	I-NP
serum  	serum  	 NNS	I-NP
was  	was  	 VBD	O
also  	also  	 RB	O
examined  	examined  	 VBN	O
( 	( 	 -LRB-	O
total  	total  	 JJ	B-NP
protein 	protein 	 NN	I-NP
,  	,  	 ,	O
albumin 	albumin 	 NN	B-NP
,  	,  	 ,	O
glucose 	glucose 	 NN	B-NP
,  	,  	 ,	O
creatinine 	creatinine 	 NN	B-NP
,  	,  	 ,	O
urea 	urea 	 NN	B-NP
,  	,  	 ,	O
uric  	uric  	 JJ	B-NP
acid 	acid 	 NN	I-NP
,  	,  	 ,	O
activities  	activities  	 NNS	O
of  	of  	 IN	O
hepatic  	hepatic  	 JJ	B-NP
transaminases 	transaminases 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
studies  	studies  	 NNS	O
revealed  	revealed  	 VBD	B-NP
changes  	changes  	 NNS	I-NP
of  	of  	 IN	O
a  	a  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
molecu  	molecu  	 JJ	B-NP
lar  	lar  	 JJ	I-NP
markers  	markers  	 NN	I-NP
that  	that  	 WDT	O
could  	could  	 MD	O
be  	be  	 VB	O
interpreted  	interpreted  	 VBN	O
as  	as  	 IN	O
unfavorable 	unfavorable 	 JJ	O
.  	.  	 .	O
These  	These  	 DT	O
include  	include  	 VBP	O
isoforms  	isoforms  	 VBN	O
of  	of  	 IN	O
CYP2B1  	CYP2B1  	 CD	B-NP
activity  	activity  	 NN	O
decrease  	decrease  	 NN	O
at  	at  	 IN	O
a  	a  	 DT	O
dose  	dose  	 FW	B-NP
HM  	HM  	 FW	I-NP
1-10  	1-10  	 FW	O
mg 	mg 	 FW	B-NP
/ 	/ 	 FW	I-NP
kg  	kg  	 FW	I-NP
of  	of  	 IN	O
body  	body  	 NN	O
weight 	weight 	 NN	O
,  	,  	 ,	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
serum  	serum  	 JJ	B-NP
content  	content  	 NN	I-NP
of  	of  	 IN	I-NP
total  	total  	 JJ	I-NP
protein 	protein 	 NN	I-NP
,  	,  	 ,	O
albumin  	albumin  	 NN	B-NP
and  	and  	 CC	O
glucose  	glucose  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
dose  	dose  	 NN	O
range  	range  	 NN	O
of  	of  	 IN	O
0.1-10  	0.1-10  	 FW	O
mg 	mg 	 FW	B-NP
/ 	/ 	 FW	I-NP
kg 	kg 	 FW	I-NP
.  	.  	 .	O
These  	These  	 DT	O
changes  	changes  	 NNS	O
were  	were  	 VBD	O
absent  	absent  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
maximum  	maximum  	 JJ	O
dose  	dose  	 NN	O
of  	of  	 IN	O
NM 	NM 	 NNP	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
did  	did  	 VBD	O
not  	not  	 RB	O
allow  	allow  	 VB	O
to  	to  	 TO	O
clearly  	clearly  	 RB	O
establish  	establish  	 VB	O
the  	the  	 DT	O
dose-response 	dose-response 	 JJ	B-NP
.  	.  	 .	O
The  	The  	 DT	O
remaining  	remaining  	 VBG	O
studied  	studied  	 VBN	O
fig  	fig  	 NNS	O
ures  	ures  	 VBP	O
resided  	resided  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
normal  	normal  	 JJ	B-NP
range  	range  	 NN	I-NP
or  	or  	 CC	O
experienced  	experienced  	 JJ	O
changes  	changes  	 NNS	O
that  	that  	 WDT	O
could  	could  	 MD	O
not  	not  	 RB	O
be  	be  	 VB	O
interpreted  	interpreted  	 VBN	O
as  	as  	 IN	O
toxic 	toxic 	 JJ	B-NP
.  	.  	 .	O
